The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services

Houston, Texas 77030

2 studies enrolling now · 3 studies all time

What they study most

Adenoid Cystic Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Cholangiocarcinoma, Endometrial Cancer, Endometrial Neoplasms, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Gallbladder Carcinoma, Gastric Cancer, HER2 Negative Breast Neoplasms, Hepatocellular Carcinoma

Studies at this site

• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors — Recruiting now
• This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. — Recruiting now
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors — Stopped early